ELEVATED CIRCULATING TUMOR-NECROSIS-FACTOR LEVELS IN ALZHEIMERS-DISEASE

被引:426
|
作者
FILLIT, H
DING, W
BUEE, L
KALMAN, J
ALTSTIEL, L
LAWLOR, B
WOLFKLEIN, G
机构
[1] MT SINAI MED CTR,RITTER DEPT GERIATR,NEW YORK,NY 10029
[2] MT SINAI MED CTR,FISHBERG CTR NEUROBIOL,DEPT MED,NEW YORK,NY 10029
[3] MT SINAI MED CTR,FISHBERG CTR NEUROBIOL,DEPT PSYCHIAT,NEW YORK,NY 10029
[4] MT SINAI MED CTR,ALZHEIMERS DIS RES CTR,NEW YORK,NY 10029
[5] PARKER JEWISH GERIATR CTR,NEW HYDE PK,NY
[6] INSERM,U156,F-59045 LILLE,FRANCE
关键词
ALZHEIMERS DISEASE; CYTOKINE; TUMOR NECROSIS FACTOR; IMMUNOPATHOLOGY;
D O I
10.1016/0304-3940(91)90490-K
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent investigations have demonstrated a local inflammatory response in Alzheimer's disease (AD), including microglia and cytokines. Levels of the cytokine tumor necrosis factor-alpha (TNF-alpha) in sera from patients with AD and age-matched controls were measured by an enzyme-linked immunoassay and a cytotoxicity bioassay. Significantly elevated levels of TNF were found in AD sera compared to controls. Elevated circulating TNF may be derived from the local CNS inflammatory reaction in AD, and may account for some systemic manifestations of AD such as weight loss. Future studies may determine if, in the absence of complicating disorders which may elevate TNF, circulating TNF could be a marker of AD inflammatory activity.
引用
收藏
页码:318 / 320
页数:3
相关论文
共 50 条
  • [11] ELEVATED LEVELS OF PLASMA TUMOR-NECROSIS-FACTOR (TNF)-ALPHA REFLECT THE ACTIVE INFLAMMATION IN PATIENTS WITH TAKAYASU DISEASE
    MATOBA, Y
    MATSUMORI, A
    CIRCULATION, 1992, 86 (04) : 308 - 308
  • [12] Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect
    Sato, Y
    Takatsu, Y
    Ito, H
    Kataoka, K
    Takeuchi, Y
    Matsumori, A
    HEART AND VESSELS, 1996, 11 (04) : 218 - 220
  • [13] BLOOD-LEVELS OF HISTAMINE, INTERLEUKIN-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA IN ALZHEIMERS-DISEASE
    ALVAREZ, XA
    FRANCOMASIDE, A
    FERNANDEZNOVOA, L
    CAAMANO, J
    GOMEZ, MJ
    NOVO, B
    ZAS, R
    CACABELOS, R
    NEUROBIOLOGY OF AGING, 1994, 15 : S93 - S93
  • [14] EFFECT OF ANTITUMOR NECROSIS FACTOR TREATMENT ON CIRCULATING TUMOR-NECROSIS-FACTOR LEVELS AND MORTALITY AFTER SURGERY IN JAUNDICED MICE
    BEMELMANS, MHA
    GOUMA, DJ
    GREVE, JW
    BUURMAN, WA
    BRITISH JOURNAL OF SURGERY, 1993, 80 (08) : 1055 - 1058
  • [15] TUMOR-NECROSIS-FACTOR IN HUMAN-DISEASE
    FAJARDO, LF
    GRAU, GE
    WESTERN JOURNAL OF MEDICINE, 1991, 154 (01): : 88 - 89
  • [16] TUMOR-NECROSIS-FACTOR, OTHER CYTOKINES AND DISEASE
    TRACEY, KJ
    CERAMI, A
    ANNUAL REVIEW OF CELL BIOLOGY, 1993, 9 : 317 - 343
  • [17] CIRCULATING INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR ANTAGONISTS IN LIVER-DISEASE
    TILG, H
    VOGEL, W
    WIEDERMANN, CJ
    SHAPIRO, L
    HEROLD, M
    JUDMAIER, G
    DINARELLO, CA
    HEPATOLOGY, 1993, 18 (05) : 1132 - 1138
  • [18] TUMOR-NECROSIS-FACTOR AND PROSTAGLANDINS IN HEALTH AND DISEASE
    FERRERI, NR
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1994, 14 (02): : 65 - 70
  • [19] TUMOR-NECROSIS-FACTOR
    WILSON, AG
    DUFF, GW
    LANCET, 1995, 345 (8950): : 649 - 649
  • [20] TUMOR-NECROSIS-FACTOR
    WAKEFIELD, PE
    JAMES, WD
    SAMLASKA, CP
    MELTZER, MS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (05) : 675 - 685